Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma

Affiliations

• ¹ Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
• ² Departmentof Oncology, Dongying City People's Hospital, Dongying, China.
• ³ Department of Pathology, Dongying City People's Hospital, Dongying, China.
• ⁴ Department of Microbiology and Immunology, Tulane University, New Orleans, LA, United States.
• ⁵ Department of Urology Surgery, Dongying Hospital of Traditional Chinese Medicine, Dongying, China.
• ⁶ Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
• ⁷ Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
• ⁸ Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.